<DOC>
	<DOCNO>NCT00919022</DOCNO>
	<brief_summary>Cyproterone acetate ( CPA ) steroidal antiandrogen affinity progesterone glucocorticoid receptor . Cyproterone acetate long-term proven effective treatment inoperable carcinoma prostate . Sexual function remain important men prostate cancer . However sexual function deteriorate fast course disease . The influence CPA sexual function remain controversial . IIEF-5 erectile dysfunction questionnaire currently widely use validate simple score system diagnose erectile dysfunction belongs use system Czech Republic . At present data CPA influence IIEF-5 score erectile dysfunction within use indication prostate cancer .</brief_summary>
	<brief_title>Androcur Non-interventional Study Among Patients With Carcinoma Prostate</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Cyproterone</mesh_term>
	<mesh_term>Cyproterone Acetate</mesh_term>
	<criteria>Males &gt; 18 year previously untreated Androcur . No contraindication Androcur . Liver diseases , malignant liver tumour waste disease ( except carcinoma prostate ) . A history exist thrombosis embolism . Severe chronic depression . Hypersensitivity cyproterone . Cyproterone acetate previous therapy .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Inoperable Prostate Cancer</keyword>
	<keyword>Erectile Dysfunction</keyword>
</DOC>